ESR2 and thyroid gland carcinoma: ERα and ERβ are both expressed in thyroid cancer cells, and the proliferation of thyroid cancer cells is promoted by an ERα agonist and reduced by enhanced expression of ERβ or by an ERβ agonist [29].